Security key
72941H509
PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PSTV)
CUSIP: 72941H509
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 183,877,102
- Total 13F shares
- 88,017
- Share change
- -13,694
- Total reported value
- $117,891
- Price per share
- $1.34
- Number of holders
- 12
- Value change
- -$18,399
- Number of buys
- 7
- Number of sells
- 2
Report period
Q3 2023
Institutions
12
Top holders
10
PSTV full security history
Newer quarter: Q4 2023
Previous quarter: Q2 2023
PLUS THERAPEUTICS, INC. SEC filings
PLUS THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 72941H509
Recent filing periods:
Top shareholders of PSTV - PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
0.04%
|
72,861
|
$147,179 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
17,007
|
$34,354 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
6,960
|
$14,059 | — | 30 Jun 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
4,731
|
$9,557 | — | 30 Jun 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
133
|
$268 | — | 30 Jun 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
18
|
$36 | — | 30 Jun 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
1
|
$2 | — | 30 Jun 2023 |
Institutional Holders of PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PSTV) as of Q3 2023
As of 30 Sep 2023,
PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PSTV) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
88,017 shares.
The largest 10 holders included
GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, HRT FINANCIAL LP, BlackRock Inc., UBS Group AG, Tower Research Capital LLC (TRC), CITIGROUP INC, OSAIC HOLDINGS, INC., and WELLS FARGO & COMPANY/MN.
This page lists
12
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
7
Q3 2023 holders
12
Holder diff
5
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.